Estimated undertreatment of carbapenem-resistant Gram-negative bacterial infections in eight low-income and middle-income countries: a modelling study
Global Antibiotic Research and Development Partnership, supported by the Governments of Canada, Germany, Japan, Monaco, the Netherlands, Switzerland, and the UK, and by the Canton of Geneva, the EU, the Bill & Melinda Gates Foundation, Global Health EDCTP3, GSK, the RIGHT Foundation, the South African Medical Research Council, and Wellcome.
Authors
- Daniel J. Morgan (ORCID: https://orcid.org/0000-0002-9467-4019)
- Ajay Kumar Mishra (ORCID: https://orcid.org/0000-0003-4862-5053)
- Jennifer Cohn
- Kim Faure
- Rahul Dwivedi
Institutions
- Global Antibiotic Research & Development Partnership (CH)
Publication Details
- Journal
- The Lancet Infectious Diseases
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/s1473-3099(25)00108-2
- Citations
- 13
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 16.40